Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers.

Li, Qingyang; Hu, Wei; Liao, Baoyi; Song, Chanchan; Li, Liangping

Li, Qingyang; Hu, Wei; Liao, Baoyi; Song, Chanchan; Li, Liangping.

Afiliación

Li Q; Department of Clinical Oncology, the First Affiliated Hospital of Jinan University, Guangzhou, China.
Hu W; T Cell Immune Technology Co., Ltd, Guangzhou, China.
Liao B; Department of Clinical Oncology, the First Affiliated Hospital of Jinan University, Guangzhou, China.
Song C; Department of Clinical Oncology, the First Affiliated Hospital of Jinan University, Guangzhou, China.
Li L; Department of Clinical Oncology, the First Affiliated Hospital of Jinan University, Guangzhou, China liangping_li@jnu.edu.cn.

J Immunother Cancer ; 10(7)2022 07.

Article en En | MEDLINE | ID: mdl-35798537

Asunto(s)

Antígenos de Neoplasias; Neoplasias; Receptores de Antígenos de Linfocitos T; Epítopos; Antígenos HLA-A; Humanos; Péptidos

Palabras clave

T-lymphocytes; antigens, neoplasm; epitope mapping; immunotherapy, adoptive; receptors, antigen

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Antígenos de Neoplasias / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google